Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-07 Sale |
2025-04-10 6:00 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
6,250 | $35.88 | $224,262 | 198,439 (Direct) |
View |
2025-03-12 Sale |
2025-03-14 8:18 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
516 | $44.88 | $23,158 | 169,721 (Direct) |
View |
2025-03-05 Sale |
2025-03-07 5:30 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,500 | $44.53 | $556,590 | 205,205 (Direct) |
View |
2025-02-05 Sale |
2025-02-07 6:05 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
18,750 | $56.51 | $1,059,630 | 217,705 (Direct) |
View |
2025-01-27 Sale |
2025-01-29 8:43 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
31,250 | $55.77 | $1,742,958 | 356,424 (Direct) |
View |
2024-12-17 Sale |
2024-12-18 8:52 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
3,800 | $31.1 | $118,172 | 393,292 (Direct) |
View |
2024-12-10 Sale |
2024-12-12 8:44 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
4,818 | $30.91 | $148,934 | 317,092 (Direct) |
View |
2024-09-10 Sale |
2024-09-13 5:11 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
537 | $26.18 | $14,059 | 180,705 (Direct) |
View |
2024-06-11 Sale |
2024-06-13 6:06 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
2,380 | $22.64 | $53,886 | 180,178 (Direct) |
View |
2024-03-13 Sale |
2024-03-15 4:42 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
619 | $28.33 | $17,536 | 182,558 (Direct) |
View |
2023-12-14 Sale |
2023-12-18 8:29 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
514 | $20.76 | $10,671 | 182,672 (Direct) |
View |
2023-09-13 Sale |
2023-09-25 8:30 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
531 | $50.34 | $26,731 | 150,689 (Direct) |
View |
2023-06-16 Sale |
2023-06-21 5:46 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
78,200 | $54.78 | $4,284,066 | 154,016 (Direct) |
View |
2023-06-13 Sale |
2023-06-15 9:35 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
509 | $55.16 | $28,076 | 189,420 (Direct) |
View |
2022-12-28 Sale |
2022-12-30 4:26 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,016 | $50.97 | $1,122,125 | 330,882 (Direct) |
View |
2022-11-15 Sale |
2022-11-16 7:15 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
7,085 | $45.28 | $320,806 | 183,837 (Direct) |
View |
2022-10-25 Sale |
2022-10-27 9:27 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
15,415 | $45.07 | $694,782 | 314,930 (Direct) |
View |
2022-09-13 Sale(A) |
2022-10-27 9:23 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,500 | $29.18 | $656,550 | 296,593 (Direct) |
View |
2022-10-06 Sale |
2022-10-07 6:00 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,500 | $39.29 | $884,025 | 247,665 (Direct) |
View |
2022-09-30 Sale |
2022-10-04 8:57 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
45,000 | $32.72 | $1,472,400 | 336,593 (Direct) |
View |
2022-09-13 Sale |
2022-09-15 7:56 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,500 | $29.18 | $656,550 | 223,837 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-07 Exercise |
2025-04-10 6:00 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
6,250 | $0 | 198,439 (Direct) |
View |
2025-04-07 Exercise |
2025-04-10 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
6,250 | $21.1 | 198,439 (Direct) |
View |
2025-03-05 Exercise |
2025-03-07 5:30 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,500 | $0 | 205,205 (Direct) |
View |
2025-03-05 Exercise |
2025-03-07 5:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
12,500 | $21.1 | 205,205 (Direct) |
View |
2025-02-05 Exercise |
2025-02-07 6:05 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
18,750 | $0 | 217,705 (Direct) |
View |
2025-02-05 Exercise |
2025-02-07 6:05 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
18,750 | $21.1 | 217,705 (Direct) |
View |
2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A 2033-12-08 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
31,250 | $0 | 356,424 (Direct) |
View |
2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
16,264 | $21.1 | 356,424 (Direct) |
View |
2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
14,986 | $19.87 | 356,424 (Direct) |
View |
2025-01-07 Gift |
2025-01-10 7:38 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
14,000 | $0 | 170,237 (Direct) |
View |
2024-12-26 Gift |
2024-12-30 8:20 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
14,100 | $0 | 184,237 (Direct) |
View |
2024-12-16 Option Award |
2024-12-18 8:52 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
80,000 | $0 | 393,292 (Direct) |
View |
2024-12-17 Exercise |
2024-12-18 8:52 pm |
N/A 2033-12-08 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
3,800 | $0 | 393,292 (Direct) |
View |
2024-12-17 Exercise |
2024-12-18 8:52 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
3,800 | $19.87 | 393,292 (Direct) |
View |
2024-12-10 Exercise |
2024-12-12 8:44 pm |
N/A 2033-12-08 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
2,450 | $0 | 317,092 (Direct) |
View |
2024-12-10 Exercise |
2024-12-12 8:44 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
2,450 | $19.87 | 317,092 (Direct) |
View |
2024-06-28 Option Award |
2024-07-02 6:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,064 | $19.94 | 181,242 (Direct) |
View |
2023-12-08 Option Award |
2023-12-12 4:38 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
178,734 | $0 | 329,423 (Direct) |
View |
2023-06-16 Exercise |
2023-06-21 5:46 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
40,000 | $0 | 154,016 (Direct) |
View |
2023-06-16 Exercise |
2023-06-21 5:46 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
40,000 | $0.61 | 154,016 (Direct) |
View |
2023-03-10 Tax Withholding |
2023-03-14 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
603 | $43.47 | 189,929 (Direct) |
View |
2022-12-28 Exercise |
2022-12-30 4:26 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
9,516 | $0 | 330,882 (Direct) |
View |
2022-12-28 Exercise |
2022-12-30 4:26 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
9,516 | $28.35 | 330,882 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 7:47 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
29,073 | $0 | 87,221 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 8:30 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
105,574 | $0 | 289,411 (Direct) |
View |
2022-10-25 Exercise |
2022-10-27 9:27 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $0 | 314,930 (Direct) |
View |
2022-10-25 Exercise |
2022-10-27 9:27 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
8,203 | $6.36 | 314,930 (Direct) |
View |
2022-10-25 Exercise |
2022-10-27 9:27 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,797 | $28.35 | 314,930 (Direct) |
View |
2022-09-13 Exercise(A) |
2022-10-27 9:23 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $0 | 296,593 (Direct) |
View |
2022-09-13 Exercise(A) |
2022-10-27 9:23 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $6.36 | 296,593 (Direct) |
View |
2022-10-06 Exercise |
2022-10-07 6:00 pm |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $0 | 247,665 (Direct) |
View |
2022-10-06 Exercise |
2022-10-07 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $21.09 | 247,665 (Direct) |
View |
2022-09-30 Exercise |
2022-10-04 8:57 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
20,000 | $0 | 336,593 (Direct) |
View |
2022-09-30 Exercise |
2022-10-04 8:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
6,328 | $6.36 | 336,593 (Direct) |
View |
2022-09-30 Exercise |
2022-10-04 8:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
13,672 | $21.09 | 336,593 (Direct) |
View |
2022-09-09 Option Award |
2022-09-13 9:14 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
58,148 | $0 | 333,559 (Direct) |
View |
2022-06-30 Option Award |
2022-09-13 9:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,152 | $8.03 | 333,559 (Direct) |
View |
2021-06-30 Option Award |
2022-09-13 9:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,007 | $21.09 | 333,559 (Direct) |
View |
2021-12-08 Option Award |
2021-12-10 5:07 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
87,221 | $0 | 87,221 (Direct) |
View |
2020-12-08 Option Award |
2020-12-09 8:49 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
77,580 | $0 | 321,758 (Direct) |
View |
2020-06-30 Option Award |
2020-12-09 8:49 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,245 | $17.07 | 321,758 (Direct) |
View |